Abstract
Pleural malignancies constitute either primary pleural malignancies, such as malignant pleural mesothelioma (MPM), or secondary pleural tumours, either from pleural metastasis or direct extension of adjacent tumours. Mesothelioma is a rare aggressive tumour of the pleural surfaces associated with prior asbestos exposure. Mesothelioma is also a challenging disease from a diagnostic staging, and treatment perspective and is rarely cured despite multimodal treatment. With incidence continuing to rise, this disease represents a serious global problem that needs urgent attention. This review provides an in-depth review of MPM. Recent advances in diagnostic approaches, such as imaging techniques and the role of immunohistochemistry and biomarkers, are discussed. Treatment modalities, including chemotherapy, radiotherapy, and surgery as part of a multimodal approach, are reviewed, as well as the management of malignant pleural effusions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
